• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氟喹诺酮类药物用于治疗成年女性急性单纯性尿路感染。

Fluoroquinolones in the treatment of acute uncomplicated urinary tract infections in adult women.

作者信息

Garrison J, Hooton T M

机构信息

Department of Pharmacy, University of Washington School of Medicine, Harborview Medical Center, Seattle 98104, USA.

出版信息

Expert Opin Pharmacother. 2001 Aug;2(8):1227-37. doi: 10.1517/14656566.2.8.1227.

DOI:10.1517/14656566.2.8.1227
PMID:11584990
Abstract

Urinary tract infections (UTIs) are among the most commonly encountered bacterial infections. Acute uncomplicated UTIs in adults include episodes of cystitis and pyelonephritis. The main uropathogens causing uncomplicated UTIs have, in the past, been fairly predictable and they have generally been susceptible to several commonly used oral antimicrobials. There has been a trend, however, towards increasing antimicrobial resistance among uropathogens over the past few years, especially to beta-lactams and trimethoprim-sulfamethoxazole (TMP-SMX). The current standard of therapy for the empiric treatment of acute uncomplicated cystitis is TMP-SMX for 3 days. Since the prevalence of resistance to TMP-SMX among uropathogens is increasing, however, fluoroquinolones, with their low side effect profile, convenient pharmacokinetics and effectiveness, are increasingly being used first-line for the management of cystitis. Treatment of acute pyelonephritis is less controversial and fluoroquinolones are recommended as first-line agents in the empiric treatment of community-acquired pyelonephritis. Of concern, the increased use of fluoroquinolones for the treatment of UTIs and other infectious processes has resulted in an increasing prevalence of fluoroquinolone-resistant uropathogens worldwide. In light of these changing resistance patterns, prudent use of fluoroquinolones for the treatment of UTIs is warranted.

摘要

尿路感染(UTIs)是最常见的细菌感染之一。成人急性单纯性尿路感染包括膀胱炎和肾盂肾炎发作。过去,引起单纯性尿路感染的主要尿路病原体相当可预测,并且它们通常对几种常用的口服抗菌药物敏感。然而,在过去几年中,尿路病原体的抗菌耐药性呈上升趋势,尤其是对β-内酰胺类和甲氧苄啶-磺胺甲恶唑(TMP-SMX)的耐药性。目前,急性单纯性膀胱炎经验性治疗的标准疗法是服用3天的TMP-SMX。然而,由于尿路病原体对TMP-SMX的耐药率不断上升,氟喹诺酮类药物因其副作用小、药代动力学特性良好且疗效显著,越来越多地被用作膀胱炎治疗的一线药物。急性肾盂肾炎的治疗争议较小,氟喹诺酮类药物被推荐作为社区获得性肾盂肾炎经验性治疗的一线药物。令人担忧的是,氟喹诺酮类药物在尿路感染和其他感染性疾病治疗中的使用增加,导致全球范围内氟喹诺酮耐药尿路病原体的患病率不断上升。鉴于这些不断变化的耐药模式,谨慎使用氟喹诺酮类药物治疗尿路感染是必要的。

相似文献

1
Fluoroquinolones in the treatment of acute uncomplicated urinary tract infections in adult women.氟喹诺酮类药物用于治疗成年女性急性单纯性尿路感染。
Expert Opin Pharmacother. 2001 Aug;2(8):1227-37. doi: 10.1517/14656566.2.8.1227.
2
Increasing antimicrobial resistance and the management of uncomplicated community-acquired urinary tract infections.日益增加的抗菌药物耐药性与非复杂性社区获得性尿路感染的管理
Ann Intern Med. 2001 Jul 3;135(1):41-50. doi: 10.7326/0003-4819-135-1-200107030-00012.
3
The current management strategies for community-acquired urinary tract infection.社区获得性尿路感染的当前管理策略。
Infect Dis Clin North Am. 2003 Jun;17(2):303-32. doi: 10.1016/s0891-5520(03)00004-7.
4
The expanding role of fluoroquinolones.氟喹诺酮类药物不断拓展的作用。
Dis Mon. 2003 Feb;49(2):129-47. doi: 10.1067/mda.2003.12.
5
Fluoroquinolones and resistance in the treatment of uncomplicated urinary tract infection.氟喹诺酮类药物与单纯性尿路感染治疗中的耐药性
Int J Antimicrob Agents. 2003 Oct;22 Suppl 2:65-72. doi: 10.1016/s0924-8579(03)00238-3.
6
Addressing antibiotic resistance.应对抗生素耐药性。
Dis Mon. 2003 Feb;49(2):99-110. doi: 10.1067/mda.2003.10.
7
Urinary tract infection: traditional pharmacologic therapies.尿路感染:传统药物治疗方法
Dis Mon. 2003 Feb;49(2):111-28. doi: 10.1067/mda.2003.11.
8
Urinary tract infection: traditional pharmacologic therapies.尿路感染:传统药物治疗
Am J Med. 2002 Jul 8;113 Suppl 1A:35S-44S. doi: 10.1016/s0002-9343(02)01058-6.
9
Nitrofurantoin compares favorably to recommended agents as empirical treatment of uncomplicated urinary tract infections in a decision and cost analysis.在决策和成本分析中,呋喃妥因作为经验性治疗单纯性尿路感染的推荐药物具有优势。
Mayo Clin Proc. 2011 Jun;86(6):480-8. doi: 10.4065/mcp.2010.0800. Epub 2011 May 16.
10
The expanding role of fluoroquinolones.氟喹诺酮类药物不断扩展的作用。
Am J Med. 2002 Jul 8;113 Suppl 1A:45S-54S. doi: 10.1016/s0002-9343(02)01059-8.

引用本文的文献

1
Chemical biology-whole genome engineering datasets predict new antibacterial combinations.化学生物学-全基因组工程数据集预测新的抗菌组合。
Microb Genom. 2021 Dec;7(12). doi: 10.1099/mgen.0.000718.
2
Community-Acquired Urinary Tract Infection by in the Era of Antibiotic Resistance.社区获得性耐药淋病奈瑟菌尿路感染。
Biomed Res Int. 2018 Sep 26;2018:7656752. doi: 10.1155/2018/7656752. eCollection 2018.
3
Adherence to International Guidelines for the Treatment of Uncomplicated Urinary Tract Infections in Lebanon.黎巴嫩对非复杂性尿路感染治疗国际指南的遵循情况。
Can J Infect Dis Med Microbiol. 2018 Feb 20;2018:7404095. doi: 10.1155/2018/7404095. eCollection 2018.
4
Quality of life and changes in symptom relief in patients with acute uncomplicated cystitis treated with antibiotics: a prospective, open-label, multicenter, observational study.抗生素治疗急性单纯性膀胱炎患者的生活质量及症状缓解变化:一项前瞻性、开放标签、多中心观察性研究。
Eur J Clin Microbiol Infect Dis. 2015 Jun;34(6):1119-24. doi: 10.1007/s10096-015-2329-6. Epub 2015 Feb 6.
5
Cutaneous leukocytoclastic vasculitis associated with levofloxacin therapy.与左氧氟沙星治疗相关的皮肤白细胞破碎性血管炎
Infect Dis Rep. 2012 Jan 30;4(1):e11. doi: 10.4081/idr.2012.e11. eCollection 2012 Jan 2.
6
Efficacy and safety of a novel once-daily extended-release ciprofloxacin tablet formulation for treatment of uncomplicated urinary tract infection in women.一种新型每日一次缓释环丙沙星片剂制剂治疗女性单纯性尿路感染的疗效与安全性。
Antimicrob Agents Chemother. 2005 Oct;49(10):4137-43. doi: 10.1128/AAC.49.10.4137-4143.2005.